World Journal of Diabetes - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Number of total visits: 7845833

Number of visits today: 14469

Number of downloads: 4806768

INDEXING/ABSTRACTING

MEMBERSHIP

BPG JOURNAL LIST

Open-Access Journal

Other Issues: Previous | Next | Latest | Archive | Download full issue 10 (2545)

Contents Volume 8 Issue 10 October 15, 2017

Review

Assessing the evidence for weight loss strategies in people with and without type 2 diabetes

Peter Clifton

World J Diabetes 8(10):440-454. Published online Oct 15, 2017. doi: 10.4239/wjd.v8.i10.440

Abstract (2140) | Core Tip (1653) | Full Article (HTML) (11510) | Tables (1-2) (1172) | Full Article (PDF)-3407K (1177) | Audio-1686K (41) | Received: 01/13/2017 | Revised: 08/15/2017 | Accepted: 09/02/2017 | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Similar Articles (8) | Timeline of Article Publication (2) | Cite | (446) | (362) | (0) | (0) | (0) | (14389) | (8) | Open

Randomized Controlled Trial

Neutral protamine hagedorn/regular insulin in the treatment of inpatient hyperglycemia: Comparison of 3 basal-bolus regimens

Dania Lizet Quintanilla-Flores, José Gerardo González-González, Guillermo García-De la Cruz, Héctor Eloy Tamez-Pérez

World J Diabetes 8(10):455-463. Published online Oct 15, 2017. doi: 10.4239/wjd.v8.i10.455

Abstract (1695) | Core Tip (1459) | Full Article (HTML) (4534) | Figures (1-2) (637) | Tables (1-4) (821) | Full Article (PDF)-2102K (490) | Audio-344K (26) | Received: 02/01/2017 | Revised: 03/28/2017 | Accepted: 05/05/2017 | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Similar Articles (0) | Timeline of Article Publication (1) | Cite | (347) | (362) | (0) | (0) | (0) | (6856) | Open

Write to the Help Desk

Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.